Trial Profile
Dose Finding and Phase II Study of STI 571 in Advanced Soft Tissue Sarcoma.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Sarcoma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 10 Sep 2005 New trial record.